ArticleBMC infectious diseases2026
Prognostic value and nonlinear association of the rdw/albumin ratio with mortality among COVID-19 patients: a MIMIC-IV database analysis.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundRDW and the RDW-to-albumin ratio (RAR) have prognostic relevance in many conditions, including COVID-19. We assessed their prognostic value, examined the potential nonlinear association of RAR with mortality, and tested whether RAR and RDW improve prediction by established ICU scores and COVID-19 prognostic markers.
methodsIn this retrospective cohort of 373 ICU COVID-19 patients from MIMIC-IV, clinical and laboratory data within 24 h of ICU admission were analyzed. RAR and RDW were divided into tertiles. Kaplan–Meier plots and Cox models were used to evaluate mortality associations after confirming model assumptions and checking collinearity. Restricted cubic splines examined RAR nonlinearity. ROC curves were used to compare the predictive accuracy of RAR and RDW. Predictive performance was then further evaluated using ROC curves, Brier scores, calibration plots, and DCA for models with and without RAR or RDW added to LDH, SOFA, SIRS, APS III, and SAPS II. Subgroup and fairness analyses were performed.
resultsA total of 31.9% of the cohort died within 28 days of ICU admission. Higher RAR was associated with increased 28-day ICU mortality, with the highest tertile showing the greatest risk. (HR = 2.12, 95% CI 1.19–3.76, P = 0.010). Trend analysis confirmed a dose-response relationship (P for trend = 0.0137). RDW did not show a significant association with 28-day ICU mortality in Model 3. RAR had better predictive performance than RDW in unadjusted and partly adjusted models (Model 1: 0.674 vs. 0.586, DBA = 0.089, P = 0.002; Model 2: 0.700 vs. 0.650, DBA = 0.051, P = 0.005). A nonlinear J-shaped relationship was identified between RAR and 28-day ICU mortality, with a threshold at 4.98. Adding RAR to LDH or SIRS improved mortality prediction across outcomes, whereas SOFA gained mainly for long-term outcomes. Subgroups confirmed more stable performance for RAR across most subgroups.
conclusionRAR outperforms RDW and shows a nonlinear relationship with mortality. RAR enhances risk prediction when added to simpler markers and SOFA, supporting its use in risk stratification among critically ill COVID-19 patients. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.